Matches in Wikidata for { <http://www.wikidata.org/entity/Q64600580> ?p ?o ?g. }
Showing items 1 to 36 of
36
with 100 items per page.
- Q64600580 description "clinical trial" @default.
- Q64600580 description "ensayu clínicu" @default.
- Q64600580 description "klinisch onderzoek" @default.
- Q64600580 description "клінічне випробування" @default.
- Q64600580 name "Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years" @default.
- Q64600580 type Item @default.
- Q64600580 label "Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years" @default.
- Q64600580 prefLabel "Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years" @default.
- Q64600580 P1132 Q64600580-5210EFC1-18FA-47CB-82DC-4AA2B4959B97 @default.
- Q64600580 P1476 Q64600580-E10C1186-BFC5-42ED-895F-A9132455A375 @default.
- Q64600580 P17 Q64600580-99BF987A-8F23-4C69-ADA3-5F6459816AFE @default.
- Q64600580 P2899 Q64600580-1E4E50BB-F157-4E2E-8218-1B32E4D0255E @default.
- Q64600580 P3098 Q64600580-0AEA034C-D5E7-4C62-9E4B-6094A2CD700A @default.
- Q64600580 P31 Q64600580-07C16E92-8287-4D09-A864-1080A9DA4A33 @default.
- Q64600580 P4135 Q64600580-AAFEF44D-4F93-45F1-AD90-1CBD7A3BEA7A @default.
- Q64600580 P580 Q64600580-47EC5B53-E8ED-41AE-B26C-6FDD54B2217F @default.
- Q64600580 P582 Q64600580-3DDE0E0D-B15A-4795-BB11-0478C9CDA28D @default.
- Q64600580 P6099 Q64600580-F83E110A-4784-4BF8-B224-4D80539DF482 @default.
- Q64600580 P6153 Q64600580-025DDF73-6EB0-47E4-82DA-A8C38F7B2893 @default.
- Q64600580 P6153 Q64600580-6FE88086-C54B-45DA-A15A-D29D0AE9CDB9 @default.
- Q64600580 P6153 Q64600580-DAC8170D-3EA1-4769-85D2-0BD183DAAE1B @default.
- Q64600580 P8363 Q64600580-3D4F08EE-951B-4569-BC37-C64E20887088 @default.
- Q64600580 P1132 "+32" @default.
- Q64600580 P1476 "A Multicenter, Open-Label, 24-Week, Uncontrolled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil Extended Release Tablets Following Transition From Remodulin or Inhaled Prostacyclin Therapy or as Add-on to Current PAH Therapy in De Novo Prostacyclin Pediatric Subjects Aged 7 to 17 Years With Pulmonary Arterial Hypertension" @default.
- Q64600580 P17 Q30 @default.
- Q64600580 P2899 "+7" @default.
- Q64600580 P3098 "NCT02276872" @default.
- Q64600580 P31 Q30612 @default.
- Q64600580 P4135 "+17" @default.
- Q64600580 P580 "2014-12-18T00:00:00Z" @default.
- Q64600580 P582 "2017-07-20T00:00:00Z" @default.
- Q64600580 P6099 Q42824440 @default.
- Q64600580 P6153 Q1468161 @default.
- Q64600580 P6153 Q41506 @default.
- Q64600580 P6153 Q5120231 @default.
- Q64600580 P8363 Q78089383 @default.